Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended March 31,				Nine Months Ended March 31,
	2024		2023		2024		2023
U.S., Canada and Latin America
Devices	$	399,281	$	372,071	$	1,116,513	$	1,057,141
Masks and other	288,191		257,070		878,647		765,364
Total U.S., Canada and Latin America	$	687,472	$	629,141	$	1,995,160	$	1,822,505
Combined Europe, Asia and other markets
Devices	$	238,919	$	235,818	$	692,411	$	611,123
Masks and other	122,632		115,157		342,344		307,913
Total Combined Europe, Asia and other markets	$	361,551	$	350,975	$	1,034,755	$	919,036
Global revenue
Total Devices	$	638,200	$	607,889	$	1,808,924	$	1,668,264
Total Masks and other	410,823		372,227		1,220,991		1,073,277
Total Sleep and Respiratory Care	$	1,049,023	$	980,116	$	3,029,915	$	2,741,541
Software as a Service	147,957		136,782		432,187		359,395
Total	$	1,196,980	$	1,116,898	$	3,462,102	$	3,100,936

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	March 31, 2024		June 30, 2023		Balance sheet caption
Contract assets
Accounts receivable, net	$	779,265	$	704,909	Accounts receivable, net
Unbilled revenue, current	37,925		31,521		Prepaid expenses and other current assets
Unbilled revenue, non-current	11,121		10,078		Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	(150,753)		(138,072)		Deferred revenue (current liabilities)
Deferred revenue, non-current	(131,981)		(119,186)		Deferred revenue (non-current liabilities)